国际标准期刊号: 2278-0238

国际药学与生命科学研究与发展杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

抽象的

Outline of Risks and Opportunities for Nepal's Pharmacy Data Systems

Haavid H

Healthcare professionals and patients can access current information on many aspects of drugs through the Drug Information Center (DIC) or Medicine Information Services. By fostering medication knowledge and supporting pharmaceutical services, medicine information services also help to reduce medication errors. This reflective commentary's main goals are to emphasize the current state of Nepal's medical information services, DIC problems,DIC strengthening strategies, and DIC prospects for the future. It is now simpler to evaluate the information in a nation like Nepal thanks to the availability of medicine information on multiple online drug information sites and programmers (apps). Before being shared, this information's veracity and dependability should be examined. By assisting doctors in using pharmaceuticals more safely and encouraging adverse drug reaction (ADR) reporting in Nepal, DIC plays a critical role in enhancing drug safety. There is not enough financial support in Nepal to run the DIC effectively, which causes operational issues. To guarantee the high quality of the service, the effectiveness of the nation's medical information services should be assessed on a regular basis. The government, private hospitals, and regulatory organizations should take action to maintain the current DIC and to build new DICs in the future to offer the community high-quality healthcare services.